Hannah Valantine sold $1.0M of CDNA
director at CareDx, Inc.. 28,779 shares at an average of $36.15, traded Jul 16, 2026, filed Jul 17, 2026.
Score components
- +15RoleDirector
- +25Trade size$1.0M at market
- +10Share of holdings soldSold 44% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001855608-26-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | MOption exercise Common Stock10b5-1 | +7,606 | $20.56 | $156k | 44,292 | Jul 17, 2026 |
| Jul 16, 2026 | MOption exercise Common Stock10b5-1 | +16,048 | $14.19 | $228k | 60,340 | Jul 17, 2026 |
| Jul 16, 2026 | MOption exercise Common Stock10b5-1 | +5,125 | $7.96 | $41k | 65,465 | Jul 17, 2026 |
| Jul 16, 2026 | SOpen-market sale Common Stock10b5-1 | -28,679 | $36.14 | $1.0M | 36,786 | Jul 17, 2026 |
| Jul 16, 2026 | SOpen-market sale Common Stock10b5-1 | -100 | $36.55 | $3,655 | 36,686 | Jul 17, 2026 |
| Jul 16, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,606 | $0.00 | $0 | 0 | Jul 17, 2026 |
| Jul 16, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -16,048 | $0.00 | $0 | 0 | Jul 17, 2026 |
| Jul 16, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,125 | $0.00 | $0 | 24,011 | Jul 17, 2026 |
Related signals
Other insiders at CareDx, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 59Moderate | CareDx, Inc. | George Bickerstaff director | $926k 20,000 shares | -13% | |
| 42Moderate | CareDx, Inc. | Christine Cournoyer director | $751k 16,000 shares | -27% | |
| 65Notable | CareDx, Inc. | Michael Goldberg director | $2.1M 44,700 shares | -42% | |
| 20Weak | CareDx, Inc. | Jeffrey Adam Novack Secretary and General Counsel | $124k 2,688 shares | -2% | |
| 28Weak | CareDx, Inc. | John Walter Hanna JR President and CEO | $4.5M 118,000 shares | -15% | |
| 23Weak | CareDx, Inc. | John Walter Hanna JR President and CEO | $1.2M 40,000 shares | -6% | |
| 29Weak | CareDx, Inc. | John Walter Hanna JR President and CEO | $425k 17,683 shares | -3% | |
| 22Weak | CareDx, Inc. | Hannah Valantine director | $280k 12,103 shares | -25% | |
| 31Weak | CareDx, Inc. | John Walter Hanna JR President and CEO | $528k 21,998 shares | -3% | |
| 23Weak | CareDx, Inc. | John Walter Hanna JR President and CEO | $116k 4,835 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.